These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 8988739

  • 21. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S.
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [Abstract] [Full Text] [Related]

  • 22. Late relapse after treatment for clinical stage I and II Hodgkin's disease.
    Brierley JD, Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, Pintillie M.
    Cancer; 1997 Apr 01; 79(7):1422-7. PubMed ID: 9083165
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
    Josting A, Nogová L, Franklin J, Glossmann JP, Eich HT, Sieber M, Schober T, Boettcher HD, Schulz U, Müller RP, Diehl V, Engert A.
    J Clin Oncol; 2005 Mar 01; 23(7):1522-9. PubMed ID: 15632410
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Favorable prognosis after late relapse of Hodgkin's disease.
    Garcia-Carbonero R, Paz-Ares L, Arcediano A, Lahuerta J, Bartolome A, Cortes-Funes H.
    Cancer; 1998 Aug 01; 83(3):560-5. PubMed ID: 9690550
    [Abstract] [Full Text] [Related]

  • 27. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N.
    Ann Hematol; 2005 Apr 01; 84(4):223-6. PubMed ID: 15042316
    [Abstract] [Full Text] [Related]

  • 28. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
    Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS.
    J Clin Oncol; 2003 May 15; 21(10):2026-33. PubMed ID: 12743158
    [Abstract] [Full Text] [Related]

  • 29. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowan T, Weinstein HJ.
    J Clin Oncol; 2004 Nov 15; 22(22):4541-50. PubMed ID: 15542805
    [Abstract] [Full Text] [Related]

  • 30. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
    Nachbaur D, Greinix HT, Koller E, Krieger O, Linkesch W, Kasparu H, Pober M, Hinterberger W, Hausmaninger H, Heistinger M, Ulsperger E, Karlhuber S, Schwinger W, Lindner B.
    Ann Hematol; 2005 Jul 15; 84(7):462-73. PubMed ID: 15726362
    [Abstract] [Full Text] [Related]

  • 31. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
    Viviani S, Bonfante V, Santoro A, Zanini M, Devizzi L, Di Russo AD, Soncini F, Villani F, Ragni G, Valagussa P, Bonadonna G.
    Cancer J Sci Am; 1999 Jul 15; 5(5):275-82. PubMed ID: 10526668
    [Abstract] [Full Text] [Related]

  • 32. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabanillas F, Hess M, Tucker S, Cox JD.
    Int J Radiat Oncol Biol Phys; 2001 Jul 15; 50(4):971-7. PubMed ID: 11429225
    [Abstract] [Full Text] [Related]

  • 33. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.
    Jpn J Clin Oncol; 2005 Mar 15; 35(3):126-33. PubMed ID: 15741302
    [Abstract] [Full Text] [Related]

  • 34. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
    He YF, Zhang YJ, Li YH, Lin TY, Xia YF, Lu TX, Huang HQ, Jiang WQ, Xian CG, He YJ, Guan ZZ.
    Ai Zheng; 2006 Dec 15; 25(12):1538-42. PubMed ID: 17166382
    [Abstract] [Full Text] [Related]

  • 35. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM.
    Sangre (Barc); 1998 Jun 15; 43(3):179-84. PubMed ID: 9741222
    [Abstract] [Full Text] [Related]

  • 36. [Clinical results of 295 patients with Hodgkin's disease treated by chemotherapy-predominant comprehensive modality].
    Huang HQ, Jiang WQ, Wang W, Xu GC, Zhang L, He YJ, Sun XF, Zhou ZM, Liu DG, Xu RH, Lin TY, Teng XY, Liu MZ, Su YS, Li YH, Lin XB, Guan ZZ.
    Ai Zheng; 2002 Dec 15; 21(12):1345-9. PubMed ID: 12520745
    [Abstract] [Full Text] [Related]

  • 37. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
    Hoppe BS, Moskowitz CH, Filippa DA, Moskowitz CS, Kewalramani T, Zelenetz AD, Yahalom J.
    J Clin Oncol; 2008 Apr 10; 26(11):1858-64. PubMed ID: 18332466
    [Abstract] [Full Text] [Related]

  • 38. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W, Moryl-Bujakowska A, Depowska T, Klekawka T, Stanuch H, Matysiak M, Sopyło B, Kołakowska-Mrozowska B, Krenke K, Chybicka A, Raś M, Sońta-Jakimczyk D, Moszant A, Wachowiak J, Kaczmarek-Kanold M, Kowalczyk J, Odój T, Balcerska A, Drozyńska E, Wysocki M, Kołtan A, Krawczuk-Rybak M, Stolarska M.
    Przegl Lek; 2004 Apr 10; 61 Suppl 2():40-4. PubMed ID: 15686044
    [Abstract] [Full Text] [Related]

  • 39. The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience.
    Olcese F, Clavio M, Rossi E, Spriano M, Ballerini F, Canepa L, Pierri I, Aquino S, Varaldo R, Manna A, Secondo V, Racchi O, Balleari E, Orcioni GF, Carella AM, Ghio R, Gobbi M.
    Ann Hematol; 2009 Sep 10; 88(9):855-61. PubMed ID: 19189105
    [Abstract] [Full Text] [Related]

  • 40. Results of treating Hodgkin's disease without a policy of laparotomy staging.
    Bergsagel DE, Alison RE, Bean HA, Brown TC, Bush RS, Clark RM, Chua T, Dalley D, DeBoer G, Gospodarowicz M, Hasselback R, Perrault D, Rideout DF.
    Cancer Treat Rep; 1982 Apr 10; 66(4):717-31. PubMed ID: 7074642
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.